Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-000212

CEO and CFO bought 2,050 shares at $23.82 ($48,831)

From the SEC's structured data for this filing

Trades in this filing

Patel Snehal · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-03 Purchase : show line 1 in the form +2,050 $23.82 $48,831 1,193,429 D
Open-market purchases · 2,050 sh · avg $23.82 · $48,831
Loading xslF345X03/ownership.xml…